Dr. Wendye Robbins will not stand for re-election to RAPT board at 2025 annual meeting

RAPT Therapeutics, Inc.

Dr. Wendye R. Robbins notified RAPT board on March 21, 2025 she will not stand for election at 2025 annual meeting.
Board reduced size from 6 to 5 directors effective at the annual meeting.
No replacement director announced; her term expires at the annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Wendye R. Robbins

Director

RAPT Therapeutics, Inc.

Filed: March 27, 2025, 7:59 PM ET

On March 21, 2025, Dr. Wendye R. Robbins notified the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”) that she will not stand for election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”) and, accordingly, her term on the Board will expire at and as of the Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Wendye R. Robbins departed as Director at RAPT Therapeutics, Inc..

Action: will not stand for election
Role: Director

Exact text from the filing

On March 21, 2025, Dr. Wendye R. Robbins notified the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”) that she will not stand for election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”) and, accordingly, her term on the Board will expire at and as of the Annual Meeting.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-25-046068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.